Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore! Learn More →

← Back to all trials

Recruiting NCT05742282

ASPIRE (Aub-haS2 Plus bIomaRkErs)

Conditions: Perioperative Medicine

Sex: All

Ages: 40 Years – N/A

Enrollment: 2500

Sponsor: Hospital Samaritano Paulista

Location: Brazil

Summary

ASPIRE is a prospective, multicenter, observational study that will assess the performance of AUB-HAS2 to predict the occurrence of major adverse cardiovascular events 30-days after a non-cardiac surgery and the additional role of high-sensitivity troponin T and NT-ProBNP biomarkers in the accuracy of different event prediction indexes after non-cardiac procedures.

Eligibility Criteria

Inclusion Criteria:Age ≥ 40 years, in the preoperative period of non-cardiac procedures, with expected hospitalization for at least 24 hours postoperatively.Exclusion Criteria:Refusal to sign the informed consent form.

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05742282). StuddyBuddy aggregates publicly available trial information.